Disclosures for "Subacute Inflammatory Demyelinating Polyneuropathy (SIDP) Secondary to Tumor Necrosis Factor (TNF)-Alpha Inhibitor (Adalimumab) for the Treatment of Rheumatoid Arthritis: A Case Report"
-
Dr. Bartnik has nothing to disclose.
-
Dr. Grady has nothing to disclose.
-
Dr. Beattie has nothing to disclose.
-
Dr. Maali has nothing to disclose.